[Clinical evaluation of a new choleretic administered in normal and high doses to patients with chronic hepatocholecytopathies].
D000328:Adult; D000368:Aged; D002164:Camphor / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002779:Cholestasis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D002756:Cholagogues and Choleretics; D002164:Camphor; C029077:camphoric acid 1-methyl ester
Valutazione clinica di un nuovo coleretico somministrato a dosi normali e ad alte dosi a epatocolecistopatici cronici.